Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $12.96 million. The enterprise value is $5.13 million.

Market Cap	12.96M
Enterprise Value	5.13M

Important Dates

The last earnings date was Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

CMMB has 7.20 million shares outstanding. The number of shares has increased by 38.23% in one year.

Current Share Class	n/a
Shares Outstanding	7.20M
Shares Change (YoY)	+38.23%
Shares Change (QoQ)	+2.02%
Owned by Insiders (%)	11.18%
Owned by Institutions (%)	8.81%
Float	6.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.16
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.31

Current Ratio	10.31
Quick Ratio	10.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -70.61% and return on invested capital (ROIC) is -46.36%.

Return on Equity (ROE)	-70.61%
Return on Assets (ROA)	-40.25%
Return on Invested Capital (ROIC)	-46.36%
Return on Capital Employed (ROCE)	-74.15%
Weighted Average Cost of Capital (WACC)	7.61%
Revenue Per Employee	n/a
Profits Per Employee	-$372,250
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.42% in the last 52 weeks. The beta is 0.61, so CMMB's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-66.42%
50-Day Moving Average	1.69
200-Day Moving Average	2.21
Relative Strength Index (RSI)	51.06
Average Volume (20 Days)	49,760

Short Selling Information

The latest short interest is 39,649, so 0.57% of the outstanding shares have been sold short.

Short Interest	39,649
Short Previous Month	47,374
Short % of Shares Out	0.57%
Short % of Float	n/a
Short Ratio (days to cover)	0.96

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.93M
Pretax Income	-7.45M
Net Income	-7.45M
EBITDA	-7.86M
EBIT	-7.93M
Earnings Per Share (EPS)	-$1.07

Balance Sheet

The company has $8.04 million in cash and n/a in debt, with a net cash position of $8.04 million or $1.12 per share.

Cash & Cash Equivalents	8.04M
Total Debt	n/a
Net Cash	8.04M
Net Cash Per Share	$1.12
Equity (Book Value)	10.70M
Book Value Per Share	1.49
Working Capital	10.36M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	74,250
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.23%
Shareholder Yield	-38.23%
Earnings Yield	-56.50%
FCF Yield	n/a

Analyst Forecast

The average price target for CMMB is $15.00, which is 733.33% higher than the current price. The consensus rating is "Buy".

Price Target	$15.00
Price Target Difference	733.33%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.

Last Split Date	Aug 26, 2025
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1